Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro (Q35663624)
Jump to navigation
Jump to search
scientific article published on 5 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro |
scientific article published on 5 December 2011 |
Statements
1 reference
Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro (English)
1 reference
Ayhan Bilir
1 reference
Mine Erguven
1 reference
Ezgi Ermis
1 reference
Mine Sencan
1 reference
Nuray Yazihan
1 reference
5 December 2011
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference